# Long Term Cardio-Vascular Risk Assessment in CKD and Kidney Transplanted Patients Following SARS-COV-2

> **NCT05125913** · — · UNKNOWN · sponsor: **Grigore T. Popa University of Medicine and Pharmacy** · enrollment: 250 (estimated)

## Conditions studied

- CKD
- Dialysis
- Kidney Transplant
- COVID-19
- Cardiovascular Disease
- Endothelial Dysfunction

## Interventions

- **DIAGNOSTIC_TEST:** FMD
- **DIAGNOSTIC_TEST:** Arterial stiffness
- **DIAGNOSTIC_TEST:** Assessment of IMT
- **DIAGNOSTIC_TEST:** Echocardiography
- **DIAGNOSTIC_TEST:** LUS
- **DIAGNOSTIC_TEST:** BIS analysis
- **OTHER:** Biomarkers determination

## Key facts

- **NCT ID:** NCT05125913
- **Lead sponsor:** Grigore T. Popa University of Medicine and Pharmacy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-04
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2022-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05125913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05125913, "Long Term Cardio-Vascular Risk Assessment in CKD and Kidney Transplanted Patients Following SARS-COV-2". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05125913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*